I agree, I enjoy discussions on here as I have for other stocks that I think are overvalued. However I do that based on clear points that are obvious. Other than cash burn over previous years, which I believe is now no longer a significant problem with revenue stepping up from cardiocel to show the underlying value of what AHZ have to offer, I just can't see logic to suggest otherwise
Nice volume, page-158
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
-1.250(8.20%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $14.80 | $14.80 | $13.60 | $165.8K | 11.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 980 | $14.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.30 | 600 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |